Combination of bevacizumab and docetaxel in docetaxel-pretreated hormone-refractory prostate cancer: a phase 2 study (Q46752908)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q39950156)
(Q4013405)
(Q4776661)
(Q17059251)
(Q45378393)
(Q108759167)
(Q125294052)
(Q87952647)
(P304) 1089-1094
(P407) (Q1860)
(P433) 5
(P478) 54
(P577) Tuesday, February 5, 2008
(P921) (Q413299)
(Q181257)
(Q420436)
(P1433) (Q15763991)
(P1476) "Combination of bevacizumab and docetaxel in docetaxel-pretreated hormone-refractory prostate cancer: a phase 2 study" (language: en)
(P2093) Giuseppe Di Lorenzo
William D Figg
Sisto Perdonà
Mario Giuliano
other details
description scientific article

External Links